NEUP vs SCHW · rev $15.7M vs P/E 19, rev $13.55B
Neuphoria Therapeutics Inc (NEUP) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Richard Andrew Wurster C.F.A., CMT.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
NEUP currently screens at market cap $23.6M. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the NEUP and SCHW stock pages for the full models.
Not investment advice.